Company lists · Data refreshed September 2026
Top 25 Immunotherapy venture capital firms based in the United States
RevenueBase identified 519 immunotherapy venture capital firms headquartered in the United States as of September 2026 and tracks 19,948 professional contacts across them, including 10,834 with verified work emails. Cambridge is the largest hub.
This list covers immunotherapy venture capital firms headquartered in the United States, matched on what each company actually does as described in its own words. Ranked by team size, largest first. Every row shows the company's own description, its RevenueBase Smart Search rating, and when it was last checked. Data refreshed September 28, 2026.
Published by RevenueBase, a B2B data infrastructure company. This list was built with RevenueBase Smart Search, the natural-language company search RevenueBase customers use to build their own targeted lists and unlock verified emails and direct dials at the companies on them. How these lists are built and judged.
The 25 largest immunotherapy venture capital firms based in the United States
Ranked by team size| # | Company | Contacts | |||
|---|---|---|---|---|---|
| 1 | 3,766 contacts → | ||||
Indirect evidence “At Kite, a Gilead Company, our singular focus is achieving cures with cell therapy.” Source: RevenueBase Database · checked Sep 28, 2026Thanks. The Data Team will review it. | |||||
| 2 | 1,952 contacts → | ||||
Indirect evidence “argenx is a global immunology company committed to improving the lives of people living with severe autoimmune diseases.” Source: RevenueBase Database · checked Sep 28, 2026Thanks. The Data Team will review it. | |||||
| 3 | 985 contacts → | ||||
Indirect evidence “Iovance Biotherapeutics (NASDAQ: IOVA) aims to be the global leader in innovating, developing and delivering tumor infiltrating lymphocyte (TIL) therapies for patients with cancer.” Source: RevenueBase Database · checked Sep 28, 2026Thanks. The Data Team will review it. | |||||
| 4 | 678 contacts → | ||||
Indirect evidence “Adaptive Biotechnologies is a pioneer and leader in immune-driven medicine that aims to improve people’s lives by learning from the wisdom of their adaptive immune systems.” Source: RevenueBase Database · checked Sep 28, 2026Thanks. The Data Team will review it. | |||||
| 5 | 637 contacts → | ||||
Partial evidence “Dendreon is a commercial-stage biopharmaceutical company and pioneer in the development of immunotherapy.” Source: RevenueBase Database · checked Sep 28, 2026Thanks. The Data Team will review it. | |||||
| 6 | 591 contacts → | ||||
Partial evidence “ImmunityBio, Inc.(formerly NantKwest, Inc.) is developing cell and immunotherapy products that are designed to help strengthen each patient’s natural immune system, potentially…” Source: RevenueBase Database · checked Sep 28, 2026Thanks. The Data Team will review it. | |||||
| 7 | 479 contacts → | ||||
Indirect evidence “Replimune's mission is to revolutionize cancer treatment with therapies designed to activate a powerful and durable full-body anti-tumor response.” Source: RevenueBase Database · checked Sep 28, 2026Thanks. The Data Team will review it. | |||||
| 8 | 296 contacts → | ||||
Indirect evidence “Benaroya Research Institute (BRI) is powering discoveries in order to learn how to rebalance the immune system in all autoimmune and immune system diseases.” Source: RevenueBase Database · checked Sep 28, 2026Thanks. The Data Team will review it. | |||||
| 9 | 213 contacts → | ||||
Indirect evidence “Lyell is a late-stage clinical company advancing a pipeline of next-generation CAR T-cell therapies for patients with cancer.” Source: RevenueBase Database · checked Sep 28, 2026Thanks. The Data Team will review it. | |||||
| 10 | 205 contacts → | ||||
Indirect evidence “Umoja is developing a new approach to cancer therapy that retools a patient’s immune system in vivo, enhancing the body’s natural capacity to fight cancer.” Source: RevenueBase Database · checked Sep 28, 2026Thanks. The Data Team will review it. | |||||
| 11 | 194 contacts → | ||||
Partial evidence “Atara Biotherapeutics Inc, is a leading allogeneic T-cell immunotherapy company pioneering the development of transformative off-the-shelf therapies for patients with serious…” Source: RevenueBase Database · checked Sep 28, 2026Thanks. The Data Team will review it. | |||||
| 12 | 190 contacts → | ||||
Indirect evidence “TScan is dedicated to creating life-changing T cell therapies for patients by unleashing the untapped potential of the human immune system.” Source: RevenueBase Database · checked Sep 28, 2026Thanks. The Data Team will review it. | |||||
| 13 | 137 contacts → | ||||
Indirect evidence “iTeos Therapeutics is a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of immuno-oncology therapeutics for patients.” Source: RevenueBase Database · checked Sep 28, 2026Thanks. The Data Team will review it. | |||||
| 14 | 135 contacts → | ||||
Partial evidence “The Cancer Research Institute (CRI) is a nonprofit organization exclusively focused on advancing cancer immunotherapy through rigorous scientific research, global collaboration…” Source: RevenueBase Database · checked Sep 28, 2026Thanks. The Data Team will review it. | |||||
| 15 | 133 contacts → | ||||
Indirect evidence “Precigen (Nasdaq: PGEN) is a biopharmaceutical company specializing in the advancement of innovative precision medicines to address difficult-to-treat diseases with high unmet…” Source: RevenueBase Database · checked Sep 28, 2026Thanks. The Data Team will review it. | |||||
| 16 | 125 contacts → | ||||
Indirect evidence “At Alumis, our goal is to significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies.” Source: RevenueBase Database · checked Sep 28, 2026Thanks. The Data Team will review it. | |||||
| 17 | 123 contacts → | ||||
Strong evidence “Atlas Venture is a leading biotech venture capital firm.” Source: RevenueBase Database · checked Sep 28, 2026Thanks. The Data Team will review it. | |||||
| 18 | 123 contacts → | ||||
Indirect evidence “RAPT is a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with inflammatory…” Source: RevenueBase Database · checked Sep 28, 2026Thanks. The Data Team will review it. | |||||
| 19 | 120 contacts → | ||||
Indirect evidence “A2 Biotherapeutics (A2 Bio) is a clinical-stage biotechnology company developing first-in-class logic-gated cell therapies to address the high unmet need in cancers and other…” Source: RevenueBase Database · checked Sep 28, 2026Thanks. The Data Team will review it. | |||||
| 20 | 118 contacts → | ||||
Indirect evidence “Cullinan Therapeutics, Inc.(Nasdaq: CGEM) is a biopharmaceutical company developing potential first- or best-in-class, disease-modifying T cell engagers for autoimmune diseases…” Source: RevenueBase Database · checked Sep 28, 2026Thanks. The Data Team will review it. | |||||
| 21 | 116 contacts → | ||||
Indirect evidence “RTW is a life sciences investment and innovation firm.” Source: RevenueBase Database · checked Sep 28, 2026Thanks. The Data Team will review it. | |||||
| 22 | 113 contacts → | ||||
Partial evidence “Janux is a clinical-stage company developing unique immunotherapies that have the potential to generate tumor-specific immune responses to attack and kill tumors without…” Source: RevenueBase Database · checked Sep 28, 2026Thanks. The Data Team will review it. | |||||
| 23 | 113 contacts → | ||||
Indirect evidence “We discover, launch and build great companies based on bold ideas that meet at the intersection of science, strategy, business and medicine – where transformational science meets…” Source: RevenueBase Database · checked Sep 28, 2026Thanks. The Data Team will review it. | |||||
| 24 | 113 contacts → | ||||
Partial evidence “TriSalus Life Sciences is an oncology company integrating novel delivery technology with immunotherapy to transform treatment for patients with liver and pancreatic tumors.” Source: RevenueBase Database · checked Sep 28, 2026Thanks. The Data Team will review it. | |||||
| 25 | 111 contacts → | ||||
Indirect evidence “Located in Redmond WA, founded in 2014, Systimmune Inc.” Source: RevenueBase Database · checked Sep 28, 2026Thanks. The Data Team will review it. | |||||
RevenueBase Smart Search
RevenueBase Smart Search assesses information from a company’s LinkedIn profile, information supplied directly by the company, its website, and other publicly available sources. It uses that information to rate how closely the company relates to this list’s category: immunotherapy venture capital firms. Every row carries its rating and the description the rating was read from, so each one can be checked rather than taken on trust.
- Strong evidence
- The company's own public description of its business names immunotherapy venture capital firms.
- Partial evidence
- Its own public description names part of immunotherapy venture capital firms, so it works in or next to the category without describing itself that way.
- Indirect evidence
- The description shown does not name immunotherapy venture capital firms. The match rests on the rest of the company's public profile rather than the one sentence quoted here, so this is the rating to check first.
RevenueBase Smart Search is how these lists are built: RevenueBase's data engine and AI assemble the companies that match a category defined in a user's own words, so a list can be about what companies actually do rather than about whichever industry code they were filed under.
Showing 25 of 519 immunotherapy venture capital firms based in the United States
See the full list, filter by size, metro and specialty, and get verified emails and direct dials for all 10,834 reachable decision-makers.
Free signup · no credit card
Immunotherapy venture capital firms based in the United States at a glance
As of Sep 28, 2026Companies by employee count
Email recency for this list is measured worldwide rather than for United States, so it is reported there. Company counts and contact totals on this page are exact for United States, over 519 companies.
How this list was built
Company categories are rarely black and white. RevenueBase reads each company's own description of its business to decide whether it belongs among immunotherapy venture capital firms, so some rows will be adjacent to the category rather than pure plays. The description and RevenueBase Smart Search rating on every row are there so you can check each match yourself.
- Source
- The RevenueBase company graph: 60 million companies and 398.9 million professional contacts resolved from primary sources, queried with RevenueBase Smart Search, the natural-language company search available to every RevenueBase user.
- What qualifies
- Companies headquartered in the United States whose own description of what they do matches “immunotherapy venture capital firms”. Matching reads each company's description, not its industry code or its name.
- RevenueBase Smart Search
- RevenueBase Smart Search is how this list is assembled and how each row is rated. RevenueBase's data engine and AI assess a company's LinkedIn profile, information supplied directly by the company, its website and other publicly available information, then relate it to a category defined in a user's own words. Each row is rated strong evidence (its own description names immunotherapy venture capital firms), partial evidence (it names part of the category) or indirect evidence (the description shown names none of it and the match rests on the rest of the company's profile). The description supporting each rating is quoted on the row.
- What we exclude
- Companies whose own description does not clearly place them among immunotherapy venture capital firms, and records with no verified work email. Companies headquartered outside United States are excluded even when they keep an office there.
- Match quality
- In blind human judging of this matching method, 86% of matched companies were on target. Expect roughly 1 in 7 rows to be adjacent to the category rather than a pure play. Every row shows the company's own description and its RevenueBase Smart Search rating so you can judge each match yourself. Read the full methodology: how the lists are built, how the judging worked, and what the figure means.
- Ranking
- Team size, largest first: companies are ordered by the number of professionals RevenueBase tracks at each one. Employee ranges shown are reported bands, for context.
- Verification
- Every listed company carries at least one verified work email, 10,834 across the full list. Contacts re-verify on a rolling cadence, and each contact's own verification date is shown inside RevenueBase.
- Refresh
- This page's figures were pulled from the company graph on September 28, 2026. Lists refresh periodically as the graph is re-checked.
- Corrections
- Wrong category, wrong headquarters, or a company that has closed? Use “Report an issue” on any row. Reports go to the RevenueBase Data Team and feed back into the company graph.
Immunotherapy venture capital firms by metro
Frequently asked
What is RevenueBase Smart Search?
RevenueBase Smart Search is how RevenueBase decides which companies belong on this list and how strongly each one fits. Its data engine and AI assess a company's LinkedIn profile, information supplied directly by the company, its website and other publicly available information, then relate it to the category the list is about. Each row is rated strong evidence when the company's own description names immunotherapy venture capital firms, partial evidence when it names part of the category, and indirect evidence when the description shown names none of it and the match rests on the rest of the company's profile.
How many immunotherapy venture capital firms are there based in the United States?
RevenueBase identified 519 immunotherapy venture capital firms headquartered in the United States as of September 2026, matched on each company's own description of what it does rather than its industry code.
What is the largest company on this list?
Kite Pharma, headquartered in Santa Monica, tops this list with the largest team on record.
Which city has the most immunotherapy venture capital firms?
Cambridge leads with 40 headquartered companies, followed by San Diego (33) and Boston (32).
How do I get contact information for these companies?
A free RevenueBase account lets you run this exact search and work the top results, verified emails and direct dials included. Upgrading unlocks all 10,834 verified decision-maker contacts tracked across these 519 companies.
How current is this list?
The list refreshes periodically as the company graph is re-checked. This page's figures were pulled on September 28, 2026.
Ready to reach these companies? Verified emails and direct dials for all 519 immunotherapy venture capital firms based in the United States. Start with a free account, no credit card.
Download this list →Related lists
Immunotherapy venture capital firms by geography
- Immunotherapy venture capital firms based in London, United Kingdom
- Immunotherapy venture capital firms based in Boston, United States
- Immunotherapy venture capital firms based in Cambridge, United States
- Immunotherapy venture capital firms based in New York, United States
- Immunotherapy venture capital firms based in San Diego, United States
- Immunotherapy venture capital firms based in Canada
- Immunotherapy venture capital firms based in France
- Immunotherapy venture capital firms based in Germany
- Immunotherapy venture capital firms based in Switzerland
- Immunotherapy venture capital firms based in the United Kingdom
About this data
RevenueBase is a B2B data infrastructure company. Its company graph covers 60 million companies and 398.9 million professional contacts, with emails verified on a rolling cadence rather than scraped once and left to decay. These company lists are generated directly from that graph with RevenueBase Smart Search, the same natural-language company search every RevenueBase user has: describe a market in plain words, get the companies that match, and add verified emails and direct dials for the people at them. It is the same data that powers RevenueBase's B2B data products, and a free account includes 500 credits to start. How these lists are built and judged.
More company lists
- All company lists
- Lists by location
- Lists A-Z
- New lists
- Immunotherapy venture capital firms based in London, United Kingdom
- Immunotherapy venture capital firms based in Boston, United States
- Immunotherapy venture capital firms based in Cambridge, United States
- Immunotherapy venture capital firms based in New York, United States
- Immunotherapy venture capital firms based in San Diego, United States
- Immunotherapy venture capital firms based in Canada